综合影像学在肝癌介入治疗疗效评估中的新进展  

New progress of comprehensive imaging in the evaluation of interventional therapy for liver cancer

作　　者：张涵 刘四斌[1] ZHANG Han;LIU Sibin(Department of Radiology,Jingzhou Hospital Affiliated to Yangtze University,Jingzhou,Hubei 434000,China;Department of Radiology,Weihai Central Hospital Affiliated to Qingdao University,Weihai,Shandong 264300,China)

机构地区：[1]长江大学附属荆州医院放射科,湖北荆州434000 [2]青岛大学附属威海市中心医院放射科,山东威海264300

出　　处：《影像研究与医学应用》2022年第19期4-6,共3页Journal of Imaging Research and Medical Applications

摘　　要：肝细胞癌在我国发病率较高且大多数患者为中晚期肝癌,失去手术切除机会。目前对于中晚期肝癌患者一线治疗方案主要采用经导管肝动脉化疗栓塞(transcatheter arterial chemoembolization,TACE)、免疫靶向药物等保守治疗。目前对治疗疗效的评估主要采用MR动态增强扫描。随着CT、多普勒彩超等一些检查方式中新技术的发展及应用,在肝癌介入治疗后的疗效评估中表现出特有的优势。本综述主要对各种无创性影像学检查的优缺点及今后可能的发展趋势进行简要的分析。Hepatocellular carcinoma has a high incidence in China,and most of the patients are advanced liver cancer,so they lose the opportunity of surgical resection.At present,the first-line treatment for patients with advanced liver cancer mainly adopts transcatheter arterial chemoembolization(TACE),immunotargeted drugs and other conservative treatments.At present,dynamic enhanced MR scanning is mainly used to evaluate the therapeutic effect.With the development and application of new technologies in some examination methods such as CT and Doppler ultrasound,it has shown its unique advantages in the evaluation of curative effect after interventional treatment of liver cancer.This review mainly analyzes the advantages and disadvantages of various non-invasive imaging examinations and the possible development trend in the future.

关 键 词：肝癌 经导管肝动脉动脉化疗栓塞 疗效评估 影像学检查 

分 类 号：R445[医药卫生—影像医学与核医学]